Vanicoside E
Vanicoside E is an antioxidant and antitumor agent. Vanicoside E inhibits L-Tyrosine and L-DOPA (HY-N0304) with IC50s of 45.23 μM and 189.96 μM, respectively[1][2].
Product Specifications
CAS Number
208707-91-9
UNSPSC
12352005
Target
Dopamine Receptor
Type
Natural Products
Related Pathways
GPCR/G Protein; Neuronal Signaling
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/vanicoside-e.html
Solubility
10 mM in DMSO
Smiles
OC(C=C1)=CC=C1/C=C/C(OC[C@@]2([C@H]([C@@H]([C@H](O2)COC(/C=C/C3=CC=C(C=C3)O)=O)O)OC(/C=C/C4=CC=C(C=C4)O)=O)O[C@@H]5[C@@H]([C@H]([C@@H]([C@H](O5)COC(/C=C/C6=CC(OC)=C(C=C6)O)=O)OC(C)=O)O)OC(C)=O)=O
Molecular Formula
C53H52O22
Molecular Weight
1040.97
References & Citations
[1]Masum M N, et al. Isolation of phenylpropanoid sucrose esters from the roots of Persicaria orientalis and their potential as inhibitors of melanogenesis. Medicinal Chemistry Research, 2019, 28: 623-632.|[2]Panda P, et al. Phenylpropanoid sucrose esters: plant-derived natural products as potential leads for new therapeutics. Curr Med Chem. 2011;18 (21) :3234-51.
Shipping Conditions
Room temperature
Scientific Category
Natural Products
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6217810-01 0.1 mL
LEF1 (Lymphoid Enhancer-Binding Factor 1, DKFZp586H0919, TCF1ALPHA) (MaxLight 550)
Sign In for Pricing
View Details MBS6217810-02 5x 0.1 mL
LEF1 (Lymphoid Enhancer-Binding Factor 1, DKFZp586H0919, TCF1ALPHA) (MaxLight 550)
Sign In for Pricing
View Details 
16090116 3x 1.0 µg
Chmp5 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Rat)
Sign In for Pricing
View Details ![Mouse Monoclonal Glyoxalase I Antibody (9F11) [DyLight 488]](https://cdn.genprice.uk/genprice/uk/genprice2.webp)
NBP2-59369G 100 µL
Mouse Monoclonal Glyoxalase I Antibody (9F11) [DyLight 488]
Sign In for Pricing
View Details